Literature DB >> 25979384

Patient specific stress and rupture analysis of ascending thoracic aneurysms.

Olfa Trabelsi1, Frances M Davis2, Jose F Rodriguez-Matas3, Ambroise Duprey4, Stéphane Avril2.   

Abstract

An ascending thoracic aortic aneurysm (ATAA) is a serious medical condition which, more often than not, requires surgery. Aneurysm diameter is the primary clinical criterion for determining when surgical intervention is necessary but, biomechanical studies have suggested that the diameter criterion is insufficient. This manuscript presents a method for obtaining the patient specific wall stress distribution of the ATAA and the retrospective rupture risk for each patient. Five human ATAAs and the preoperative dynamic CT scans were obtained during elective surgeries to replace each patient's aneurysm with a synthetic graft. The material properties and rupture stress for each tissue sample were identified using bulge inflation tests. The dynamic CT scans were used to generate patient specific geometries for a finite element (FE) model of each patient's aneurysm. The material properties from the bulge inflation tests were implemented in the FE model and the wall stress distribution at four different pressures was estimated. Three different rupture risk assessments were compared: the maximum diameter, the rupture risk index, and the overpressure index. The peak wall stress values for the patients ranged from 28% to 94% of the ATAA's failure stress. The rupture risk and overpressure indices were both only weakly correlated with diameter (ρ=-0.29, both cases). In the future, we plan to conduct a large experimental and computational study that includes asymptomatic patients under surveillance, patients undergoing elective surgery, and patients who have experienced rupture or dissection to determine if the rupture risk index or maximum diameter can meaningfully differentiate between the groups.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aneurysm rupture; Ascending thoracic aortic aneurysm; Finite element analysis; Patient specific material properties; Rupture risk; Wall stress

Mesh:

Year:  2015        PMID: 25979384     DOI: 10.1016/j.jbiomech.2015.04.035

Source DB:  PubMed          Journal:  J Biomech        ISSN: 0021-9290            Impact factor:   2.712


  6 in total

1.  Failure of the Porcine Ascending Aorta: Multidirectional Experiments and a Unifying Microstructural Model.

Authors:  Colleen M Witzenburg; Rohit Y Dhume; Sachin B Shah; Christopher E Korenczuk; Hallie P Wagner; Patrick W Alford; Victor H Barocas
Journal:  J Biomech Eng       Date:  2017-03-01       Impact factor: 2.097

2.  Ex Vivo Mechanical Tests and Multiscale Computational Modeling Highlight the Importance of Intramural Shear Stress in Ascending Thoracic Aortic Aneurysms.

Authors:  Christopher E Korenczuk; Rohit Y Dhume; Kenneth Liao; Victor H Barocas
Journal:  J Biomech Eng       Date:  2019-10-01       Impact factor: 2.097

3.  Impact of Patient-Specific Material Properties on Aneurysm Wall Stress: Finite Element Study.

Authors:  Zhongjie Wang; Yue Xuan; Julius M Guccione; Elaine E Tseng; Liang Ge
Journal:  J Heart Valve Dis       Date:  2018

4.  Regulation of SMC traction forces in human aortic thoracic aneurysms.

Authors:  Claudie Petit; Ali-Akbar Karkhaneh Yousefi; Olfa Ben Moussa; Jean-Baptiste Michel; Alain Guignandon; Stéphane Avril
Journal:  Biomech Model Mechanobiol       Date:  2021-01-15

5.  Multimodality Imaging-Based Characterization of Regional Material Properties in a Murine Model of Aortic Dissection.

Authors:  Matthew R Bersi; Víctor A Acosta Santamaría; Karl Marback; Paolo Di Achille; Evan H Phillips; Craig J Goergen; Jay D Humphrey; Stéphane Avril
Journal:  Sci Rep       Date:  2020-06-08       Impact factor: 4.379

6.  About prestretch in homogenized constrained mixture models simulating growth and remodeling in patient-specific aortic geometries.

Authors:  Joan D Laubrie; S Jamaleddin Mousavi; Stéphane Avril
Journal:  Biomech Model Mechanobiol       Date:  2022-01-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.